Resources for Journalists

COVID-19 is a disease caused by the SARS-CoV-2 virus strain, that has not been previously identified in humans. See below for a collection of resources to help you cover this issue (Please note: additional resources are available to journalists who are logged in).

The AusSMC also issues a daily COVID-19 update for registered journalists (click here to view an example). If you would like to receive this email, please go to your profile on MyScimex and select yes beside "Receive COVID-19 Updates?". The email update and this resources page are supported by the Google News Initiative.

Latest COVID-19 news, research, expert reactions and briefings

Show/Hide newsfeed filter Filter by
Type
News for

Choose a location of interest

  1. Early UK data suggests hospitalisation risk is lower for Omicron than for Delta

    Publicly released: Thu 23 Dec 2021 at 1030 AEDT, 1230 NZDT

    It includes all PCR-confirmed SARS-CoV-2 cases in England between 1-14 December 2021 where the variant causing infection could be identified from genetic data or via S gene ... Since the emergence of the Read more about Early UK data suggests hospitalisation risk is lower for Omicron than for Delta

    InternationalImperial College London, University of Edinburgh, UK

  2. 87% lower risk of severe COVID-19 in remdesivir trial

    Publicly released: Thu 23 Dec 2021 at 0900 AEDT, 1100 NZDT

    The New England Journal of Medicine

    Remdesivir is known to help people in hospital with COVID-19 but a new study has looked at the effects on less severe cases. ... In this US trial, only two remdesivir patients (0. 7%) were hospitalised or Read more about 87% lower risk of severe COVID-19 in remdesivir trial

    InternationalBaylor University Medical Center, Center for Advanced Heart and Lung Disease (US)

  3. Why is COVID-19 milder in kids?

    Publicly released: Thu 23 Dec 2021 at 0819 AEDT, 1019 NZDT

    Nature

    Scientists are still figuring out how COVID-19 develops differently in children and adults. ... A team has delved into molecular variations by comparing nasal, tracheal, bronchial and blood samples from Read more about Why is COVID-19 milder in kids?

    InternationalUniversity College London, Wellcome Sanger Institute, University College London Hospitals NHS Foundation Trust, Royal Free Hospital NHS Foundation Trust, University of Cambridge, Newcastle University (UK) and Jikei University School of Medicine (Japan) and Northwestern University Feinberg School of Medicine (US)

  4. Excessive smartphone use during pandemic could be giving you FOMO

    Publicly released: Thu 23 Dec 2021 at 0600 AEDT, 0800 NZDT

    PLOS ONE

    Excessive smartphone use during the COVID-19 pandemic could be giving you the fear of missing out (FOMO), a low sense of control, and repetitive thinking, according to an international study. Read more about Excessive smartphone use during pandemic could be giving you FOMO

    InternationalRuhr-Universitat Bochum, Germany

  5. Unvaccinated up to 4 times more likely to be infected with COVID-19

    Publicly released: Thu 23 Dec 2021 at 0300 AEDT, 0500 NZDT

    Jama Network Open

    Carried out in May to August 2021 when Delta became dominant, this US study looked at the COVID-19 tests of over 1. ... 2 million people from the database of a nationwide pharmacy chain. Read more about Unvaccinated up to 4 times more likely to be infected with COVID-19

    InternationalCVS Health, US

  6. Post-shot side effects common - but serious reactions sparse

    Publicly released: Thu 23 Dec 2021 at 0300 AEDT, 0500 NZDT

    JAMA Network Open

    People were more likely to experience negative effects after their second dose of a COVID-19 shot, with the Moderna vaccine, and if they were younger or female. ... This research also found a strong link Read more about Post-shot side effects common - but serious reactions sparse

    InternationalUniversity of California - San Francisco, US

  7. How important are T cells in the fight against COVID-19?

    Publicly released: Wed 22 Dec 2021 at 1101 AEDT, 1301 NZDT

    Royal Society Open Science

    hundreds of COVID-19 patients to find out the role these cells have played at preventing death and helping clear the virus. ... Can humans develop effective long-term immunity against the COVID-19 virus, Read more about How important are T cells in the fight against COVID-19?

    InternationalPeking University, China

  8. Jab may prevent severe COVID-19 complication in teens

    Publicly released: Wed 22 Dec 2021 at 1034 AEDT, 1234 NZDT

    JAMA

    Of the 33 teens admitted to all French ICUs with this complication of COVID-19 in September and October 2021, none had been fully vaccinated and 7 had received one dose. ... Most of these seven became Read more about Jab may prevent severe COVID-19 complication in teens

    InternationalHôpital Universitaire Robert-Debré, Université de Lille, Hôpital Femme Mère Enfant, Centre Hospitalier Universitaire de Martinique (France)

  9. Staying a step ahead: Australian scientists develop highly accurate point-of-care neutralising antibodies (NAb) test for COVID-19

    Publicly released: Tue 21 Dec 2021 at 1605 AEDT, 1805 NZDT

    EBioMedicine

    antibodies (NAb) to COVID-19 – including variants – developed by Burnet Institute and the Peter Doherty Institute for Infection and Immunity (Doherty Institute) scientists. ... While there are many Read more about Staying a step ahead: Australian scientists develop highly accurate point-of-care neutralising antibodies (NAb) test for COVID-19

    Australia; VICBurnet Institute

  10. EXPERT REACTION: COVID-19 cases booming as Christmas is looming

    Publicly released: Tue 21 Dec 2021 at 1300 AEDT, 1500 NZDT

    With Christmas just days away, COVID-19 cases are hitting never before seen peaks across the country. ... Below Australian experts comment on the current situation and what we can do to stay safe this Read more about EXPERT REACTION: COVID-19 cases booming as Christmas is looming

    Australia; NSW; VIC; QLD; SA; WA; TASAustralian Science Media Centre

  11. mRNA vaccines reduced death risk by 89% at the beginning of 2021

    Publicly released: Tue 21 Dec 2021 at 0900 AEDT, 1100 NZDT

    Annals of Internal Medicine

    About 2 million veterans vaccinated in the first three months of 2021, mostly male, were included in the study which tracked COVID-19 deaths and infections in the cohort until June ... The researchers Read more about mRNA vaccines reduced death risk by 89% at the beginning of 2021

    InternationalUniversity of Washington, USA

  12. Nine in 10 kids in ICU for COVID-19 had prior medical conditions

    Publicly released: Tue 21 Dec 2021 at 0733 AEDT, 0933 NZDT

    Nature Medicine

    Research in England has pinpointed what puts children and young people at risk of severe COVID-19, drawing on all hospitalisations under 18 in the first pandemic year. ... Of the 251 children and teens Read more about Nine in 10 kids in ICU for COVID-19 had prior medical conditions

    InternationalInstitute of Child Health, University of Liverpool, Alder Hey Children’s NHS Foundation Trust, NHS England and Improvement, Bristol Royal Hospital for Children, University of Leicester, Imperial College London, etc. (UK)

  13. Three-times higher chance of catching COVID-19 six months after jab

    Publicly released: Tue 21 Dec 2021 at 0645 AEDT, 0845 NZDT

    NEJM Evidence

    4 times more likely to catch COVID-19 than people jabbed more recently; this trend was found across ages and vaccines. ... This study found the Moderna vaccine’s protection was sustained in regard to Read more about Three-times higher chance of catching COVID-19 six months after jab

    InternationalCenters for Disease Control and Prevention, Utah Department of Health, New Jersey Department of Health, New York City Department of Health and Mental Hygiene, Massachusetts Department of Public Health, Michigan Department of Health and Human Services, etc. (US)

  14. Severe gastrointestinal symptoms common in kids with COVID-19

    Publicly released: Tue 21 Dec 2021 at 0300 AEDT, 0500 NZDT

    JAMA Network Open

    A study of Italian kids with COVID-19 has found that around 1 in 10 have severe gastrointestinal symptoms and the symptoms are often associated with the multisystem inflammatory syndrome, known Read more about Severe gastrointestinal symptoms common in kids with COVID-19

    InternationalUniversity of Naples, Italy

  15. Mandatory masks for adults may help stop school outbreaks

    Publicly released: Mon 20 Dec 2021 at 1600 AEDT, 1800 NZDT

    Frontiers in Public Health

    The role of children and adolescents in the spread of Covid-19 remains unclear, yet closures of schools and preschools have become a common approach to try to prevent outbreaks. ... First author Dr. Read more about Mandatory masks for adults may help stop school outbreaks

    InternationalUniversity Medicine Greifswald, Germany; University Hospital Rostock, Germany; Landesamt für Gesundheit und Soziales Mecklenburg-Vorpommern State Office for Health and Social Affairs, Germany

  16. Indigenous Americans ahead on COVID shots - what are the lessons?

    Publicly released: Mon 20 Dec 2021 at 1012 AEDT, 1212 NZDT

    New England Journal of Medicine

    Portraying COVID-19 vaccination as the best way to prevent further suffering given disproportionate harms was a crucial strategy according to a poll. ... The authors say tribal autonomy to decide their Read more about Indigenous Americans ahead on COVID shots - what are the lessons?

    InternationalFirst Nations Development Institute, University of North Dakota, Yale University, Harvard Medical School, the Center for Social Policy and the Native American Budget and Policy Institute, University of New Mexico, University of Miami (US)

  17. Risk of myocarditis after mRNA COVID-19 vaccination is low, even in younger people

    Publicly released: Fri 17 Dec 2021 at 1030 AEDT, 1230 NZDT

    The BMJ

    today provides more reassuring data on the risk of heart inflammation (myocarditis or myopericarditis) after mRNA vaccination against the covid-19 virus. ... age groups, providing further evidence to Read more about Risk of myocarditis after mRNA COVID-19 vaccination is low, even in younger people

    InternationalStatens Serum Institute, Denmark

  18. Merck's COVID-19 pill reduces risk of hospitalisation and death

    Publicly released: Fri 17 Dec 2021 at 0900 AEDT, 1100 NZDT

    New England Journal of Medicine

    Merck's COVID-19 pill molnupiravir can reduce the risk of hospitalisation and death when taken soon after contracting COVID-19, according to the results of its phase 3 trial which ... 7 per cent in the Read more about Merck's COVID-19 pill reduces risk of hospitalisation and death

    InternationalMerck, USA

  19. Power cut: Kiwis used 12% less in lockdown

    Publicly released: Fri 17 Dec 2021 at 0606 AEDT, 0806 NZDT

    Sustainable Energy, Grids and Networks

    An NZ-China team has delved into how COVID-19 measures affected electricity demand in the year to February 2021. ... This “dry year problem” needs to be tackled to develop a more sustainable Read more about Power cut: Kiwis used 12% less in lockdown

    New ZealandUniversity of Auckland | China University of Geosciences, China

  20. Cough or fever? First COVID-19 symptoms may differ depending on the variant

    Publicly released: Fri 17 Dec 2021 at 0600 AEDT, 0800 NZDT

    PLOS Computational Biology

    An early change in the virus that causes COVID-19 seems to have changed the order in which symptoms appeared in patients, according to international research. ... Cough or fever first? Study analyzes Read more about Cough or fever? First COVID-19 symptoms may differ depending on the variant

    InternationalUniversity of Southern California, USA

Show Results

  1. 10
  2. 20
  3. 50